A 45-year-old Aboriginal man from a remote Northern Territory community has a history of rheumatic heart disease with moderate mitral regurgitation. He had an episode of acute rheumatic fever aged 14 years. He has limited access to health services but attends the local clinic monthly. What is the most appropriate ongoing secondary prophylaxis regimen?